Showing results (71-80 of 213) with videos related to

Sort By:
Pageof 22
BJU International|December 13, 2006
Toxicity following high-dose salvage radiotherapy after radical prostatectomyCharlie Jung, Michael S Cookson, Sam S Chang, et al.
The Journal of Urology|October 9, 2003
Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: development and validation of a new disease specific questionnaireMichael S Cookson, Sajal C Dutta, Sam S Chang, et al.
The Journal of Urology|January 17, 2002
Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladderRandy G Nixon, Sam S Chang, Bonnie J Lafleur, et al.
The Journal of Urology|March 20, 2012
National practice patterns for immediate postoperative instillation of chemotherapy in nonmuscle invasive bladder cancerMichael S Cookson, Sam S Chang, Michael G Oefelein, et al.
The Journal of Urology|April 13, 2004
Predicting blood loss and transfusion requirements during radical prostatectomy: the significant negative impact of increasing body mass indexSam S Chang, David T Duong, Nancy Wells, et al.
The Journal of Urology|June 7, 2002
Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladderSajal C Dutta, Sam C Chang, Christopher S Coffey, et al.
The Journal of Urology|June 7, 2002
Beneficial impact of a clinical care pathway in patients with testicular cancer undergoing retroperitoneal lymph node dissectionSam S Chang, Joseph A Smith, Christopher Girasole, et al.
Cancer|February 8, 2017
Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinomaRyan P Kopp, Kelly L Stratton, Emily Glogowski, et al.
BJU International|April 25, 2009
Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathologyDaniel A Barocas, Sanjay G Patel, Sam S Chang, et al.
Urologic Oncology|March 20, 2003
The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSADavid J Grossklaus, Joseph A Smith, Scott B Shappell, et al.
Pageof 22